Inventiva (IVA) Notes Payables (2018 - 2025)
Inventiva (IVA) recorded quarterly Notes Payables of $6.3 billion in Q2 2025, little changed quarter-over-quarter from $6.3 billion in Q4 2024, and up 101471.04% on a YoY basis from N/an in Q2 2024.
Inventiva (IVA) Notes Payables (2018 - 2025) Analysis & Trends
Inventiva's Notes Payables history runs 8 years deep, the most recent figure standing at $6.3 billion for Q2 2025.
- In Q2 2025, Notes Payables rose 101471.04% year-over-year to $6.3 billion; the TTM figure through Jun 2025 stood at $6.3 billion (up 101471.04% YoY), while the FY2024 annual figure was $6.3 billion, changed N/A from the prior year.
- Notes Payables was $6.3 billion for Q2 2025 at Inventiva, roughly flat from $6.3 billion in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $6.3 billion in Q4 2024 to a low of $13268.6 in Q1 2021.
- Historically, Notes Payables has averaged $2.4 billion across 5 years, with a median of $736.5 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Notes Payables surged 32239824.15% in 2022, then tumbled 99.88% in 2023.
- A 5-year view of Notes Payables shows it stood at $1.5 billion in 2021, then jumped by 270.63% to $5.4 billion in 2022, then tumbled by 99.88% to $6.4 million in 2023, then soared by 98318.24% to $6.3 billion in 2024, then dropped by 0.12% to $6.3 billion in 2025.
- The last three Notes Payables figures came in at $6.3 billion (Q2 2025), $6.3 billion (Q4 2024), and $6.2 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 6.26 Bn |
| Dec 31, 2024 | 6.27 Bn |
| Jun 30, 2024 | 6.17 Mn |
| Jun 30, 2023 | 6.37 Mn |
| Jun 30, 2022 | 5.44 Bn |
| Dec 31, 2021 | 1.47 Bn |
| Jun 30, 2021 | 16,859.80 |
| Mar 31, 2021 | 13,268.60 |
| Dec 31, 2020 | 21,461.22 |
| Jun 30, 2020 | 11.04 Mn |
| Dec 31, 2019 | 125,078.31 |
| Dec 31, 2018 | 172,350.86 |